Ask why a pharmacy-made version is proposed.

Ask how this differs from a finished product

• Who would prepare the medicine?
• What change is being made for me?

Keep in mind FDA approval does not cover a medicine prepared to order. As checked on September 26, 2026, the US medicines agency did not check its safety, quality or results before sale.

FDA reports checked on September 26, 2026 described harm that may have come from errors in the amount of pharmacy-made semaglutide injected. Patients sometimes measured the wrong amount for their own shot. In other cases, health professionals calculated the amount wrongly. Some people needed hospital care.

Question a shortage-based explanation

• Is the explanation based on a national shortage or local stock?
• What rule allows this pharmacy-made version for me?

Keep in mind The FDA ended the national shortage listing for semaglutide injections on February 21, 2025, according to its record checked on September 26, 2026.

Trouble finding stock locally does not by itself place a medicine on the FDA's national shortage list.

As of September 26, 2026, ordinary pharmacies could not routinely make a copy of a medicine already available to buy. An exception applied when the person prescribing it decided that a change made a significant difference for a named patient. A price reduction by itself did not qualify as such a change.

Get an explanation of the change proposed for your medicine and its importance to your health. Ask the person prescribing it to explain the rule that permits that change.

Ask what the ingredient change means

• Is a vitamin being added, and why does that matter for me?
• What exact ingredient name appears on the label or invoice?

Keep in mind The FDA's position checked on September 26, 2026 was that adding a vitamin to a similar semaglutide injection could still count as copying the available medicine. Adding a vitamin alone did not make it allowed. The person prescribing it had to record a change that made a significant difference for that patient.

Look for the full names semaglutide sodium or semaglutide acetate. Here, sodium and acetate name different chemical versions of the medicine, called salt forms. These names tell you the ingredient differs from the one in approved semaglutide products.

As of September 26, 2026, the FDA knew of no lawful basis for making medicines to order with semaglutide sodium or semaglutide acetate. It also did not know whether they acted the same way as the ingredient in approved products.